Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1999 Oct;8(10):1930–1945. doi: 10.1110/ps.8.10.1930

Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.

N G Oikonomakos 1, K E Tsitsanou 1, S E Zographos 1, V T Skamnaki 1, S Goldmann 1, H Bischoff 1
PMCID: PMC2144149  PMID: 10548038

Abstract

The effect of the potential antidiabetic drug (-)(S)-3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbox ylate (W1807) on the catalytic and structural properties of glycogen phosphorylase a has been studied. Glycogen phosphorylase (GP) is an allosteric enzyme whose activity is primarily controlled by reversible phosphorylation of Ser14 of the dephosphorylated enzyme (GPb, less active, predominantly T-state) to form the phosphorylated enzyme (GPa, more active, predominantly R-state). Upon conversion of GPb to GPa, the N-terminal tail (residues 5-22), which carries the Ser14(P), changes its conformation into a distorted 3(10) helix and its contacts from intrasubunit to intersubunit. This alteration causes a series of tertiary and quaternary conformational changes that lead to activation of the enzyme through opening access to the catalytic site. As part of a screening process to identify compounds that might contribute to the regulation of glycogen metabolism in the noninsulin dependent diabetes diseased state, W1807 has been found as the most potent inhibitor of GPb (Ki = 1.6 nM) that binds at the allosteric site of T-state GPb and produces further conformational changes, characteristic of a T'-like state. Kinetics show W1807 is a potent competitive inhibitor of GPa (-AMP) (Ki = 10.8 nM) and of GPa (+1 mM AMP) (Ki = 19.4 microM) with respect to glucose 1-phosphate and acts in synergism with glucose. To elucidate the structural features that contribute to the binding, the structures of GPa in the T-state conformation in complex with glucose and in complex with both glucose and W1807 have been determined at 100 K to 2.0 A and 2.1 A resolution, and refined to crystallographic R-values of 0.179 (R(free) = 0.230) and 0.189 (R(free) = 0.263), respectively. W1807 binds tightly at the allosteric site and induces substantial conformational changes both in the vicinity of the allosteric site and the subunit interface. A disordering of the N-terminal tail occurs, while the loop of chain containing residues 192-196 and residues 43'-49' shift to accommodate the ligand. Structural comparisons show that the T-state GPa-glucose-W1807 structure is overall more similar to the T-state GPb-W1807 complex structure than to the GPa-glucose complex structure, indicating that W1807 is able to transform GPa to the T'-like state already observed with GPb. The structures provide a rational for the potency of the inhibitor and explain GPa allosteric inhibition of activity upon W1807 binding.

Full Text

The Full Text of this article is available as a PDF (8.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barford D., Hu S. H., Johnson L. N. Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. J Mol Biol. 1991 Mar 5;218(1):233–260. doi: 10.1016/0022-2836(91)90887-c. [DOI] [PubMed] [Google Scholar]
  2. Barford D., Johnson L. N. The allosteric transition of glycogen phosphorylase. Nature. 1989 Aug 24;340(6235):609–616. doi: 10.1038/340609a0. [DOI] [PubMed] [Google Scholar]
  3. Bollen M., Stalmans W. The structure, role, and regulation of type 1 protein phosphatases. Crit Rev Biochem Mol Biol. 1992;27(3):227–281. doi: 10.3109/10409239209082564. [DOI] [PubMed] [Google Scholar]
  4. Cohen P. The subunit structure of rabbit-skeletal-muscle phosphorylase kinase, and the molecular basis of its activation reactions. Eur J Biochem. 1973 Apr 2;34(1):1–14. doi: 10.1111/j.1432-1033.1973.tb02721.x. [DOI] [PubMed] [Google Scholar]
  5. Fletterick R. J., Madsen N. B. The structures and related functions of phosphorylase a. Annu Rev Biochem. 1980;49:31–61. doi: 10.1146/annurev.bi.49.070180.000335. [DOI] [PubMed] [Google Scholar]
  6. Fletterick R. J., Sygusch J., Murray N., Madsen N. B. Low-resolution structure of the glycogen phosphorylase alpha monomer and comparison with phosphorylase beta. J Mol Biol. 1976 May 5;103(1):1–13. doi: 10.1016/0022-2836(76)90048-6. [DOI] [PubMed] [Google Scholar]
  7. Gregoriou M., Noble M. E., Watson K. A., Garman E. F., Krulle T. M., de la Fuente C., Fleet G. W., Oikonomakos N. G., Johnson L. N. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding. Protein Sci. 1998 Apr;7(4):915–927. doi: 10.1002/pro.5560070409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HELMREICH E., CORI C. F. THE ROLE OF ADENYLIC ACID IN THE ACTIVATION OF PHOSPHORYLASE. Proc Natl Acad Sci U S A. 1964 Jan;51:131–138. doi: 10.1073/pnas.51.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Johnson L. N. Glycogen phosphorylase: control by phosphorylation and allosteric effectors. FASEB J. 1992 Mar;6(6):2274–2282. doi: 10.1096/fasebj.6.6.1544539. [DOI] [PubMed] [Google Scholar]
  10. Johnson L. N., Snape P., Martin J. L., Acharya K. R., Barford D., Oikonomakos N. G. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b. J Mol Biol. 1993 Jul 5;232(1):253–267. doi: 10.1006/jmbi.1993.1380. [DOI] [PubMed] [Google Scholar]
  11. Jones T. A., Zou J. Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
  12. Kastenschmidt L. L., Kastenschmidt J., Helmreich E. Subunit interactions and their relationship to the allosteric properties of rabbit skeletal muscle phosphorylase b. Biochemistry. 1968 Oct;7(10):3590–3608. doi: 10.1021/bi00850a037. [DOI] [PubMed] [Google Scholar]
  13. Kasvinsky P. J., Shechosky S., Fletterick R. J. Synergistic regulation of phosphorylase a by glucose and caffeine. J Biol Chem. 1978 Dec 25;253(24):9102–9106. [PubMed] [Google Scholar]
  14. MONOD J., WYMAN J., CHANGEUX J. P. ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. J Mol Biol. 1965 May;12:88–118. doi: 10.1016/s0022-2836(65)80285-6. [DOI] [PubMed] [Google Scholar]
  15. Martin J. L., Veluraja K., Ross K., Johnson L. N., Fleet G. W., Ramsden N. G., Bruce I., Orchard M. G., Oikonomakos N. G., Papageorgiou A. C. Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes. Biochemistry. 1991 Oct 22;30(42):10101–10116. doi: 10.1021/bi00106a006. [DOI] [PubMed] [Google Scholar]
  16. Martin W. H., Hoover D. J., Armento S. J., Stock I. A., McPherson R. K., Danley D. E., Stevenson R. W., Barrett E. J., Treadway J. L. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1776–1781. doi: 10.1073/pnas.95.4.1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Melpidou A. E., Oikonomakos N. G. Effect of glucose-6-P on the catalytic and structural properties of glycogen phosphorylase a. FEBS Lett. 1983 Apr 5;154(1):105–110. doi: 10.1016/0014-5793(83)80884-9. [DOI] [PubMed] [Google Scholar]
  18. Oikonomakos N. G., Kontou M., Zographos S. E., Watson K. A., Johnson L. N., Bichard C. J., Fleet G. W., Acharya K. R. N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose. Protein Sci. 1995 Dec;4(12):2469–2477. doi: 10.1002/pro.5560041203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Oikonomakos N. G., Zographos S. E., Johnson L. N., Papageorgiou A. C., Acharya K. R. The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies. J Mol Biol. 1995 Dec 15;254(5):900–917. doi: 10.1006/jmbi.1995.0665. [DOI] [PubMed] [Google Scholar]
  20. Owen D. J., Papageorgiou A. C., Garman E. F., Noble M. E., Johnson L. N. Expression, purification and crystallisation of phosphorylase kinase catalytic domain. J Mol Biol. 1995 Feb 24;246(3):374–381. doi: 10.1006/jmbi.1994.0092. [DOI] [PubMed] [Google Scholar]
  21. Sprang S. R., Acharya K. R., Goldsmith E. J., Stuart D. I., Varvill K., Fletterick R. J., Madsen N. B., Johnson L. N. Structural changes in glycogen phosphorylase induced by phosphorylation. Nature. 1988 Nov 17;336(6196):215–221. doi: 10.1038/336215a0. [DOI] [PubMed] [Google Scholar]
  22. Sprang S. R., Goldsmith E. J., Fletterick R. J., Withers S. G., Madsen N. B. Catalytic site of glycogen phosphorylase: structure of the T state and specificity for alpha-D-glucose. Biochemistry. 1982 Oct 12;21(21):5364–5371. doi: 10.1021/bi00264a038. [DOI] [PubMed] [Google Scholar]
  23. Sprang S. R., Withers S. G., Goldsmith E. J., Fletterick R. J., Madsen N. B. Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate. Science. 1991 Nov 29;254(5036):1367–1371. doi: 10.1126/science.1962195. [DOI] [PubMed] [Google Scholar]
  24. Sprang S., Goldsmith E., Fletterick R. Structure of the nucleotide activation switch in glycogen phosphorylase a. Science. 1987 Aug 28;237(4818):1012–1019. doi: 10.1126/science.3616621. [DOI] [PubMed] [Google Scholar]
  25. Street I. P., Armstrong C. R., Withers S. G. Hydrogen bonding and specificity. Fluorodeoxy sugars as probes of hydrogen bonding in the glycogen phosphorylase-glucose complex. Biochemistry. 1986 Oct 7;25(20):6021–6027. doi: 10.1021/bi00368a028. [DOI] [PubMed] [Google Scholar]
  26. Tsitsanou K. E., Oikonomakos N. G., Zographos S. E., Skamnaki V. T., Gregoriou M., Watson K. A., Johnson L. N., Fleet G. W. Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure. Protein Sci. 1999 Apr;8(4):741–749. doi: 10.1110/ps.8.4.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zographos S. E., Oikonomakos N. G., Tsitsanou K. E., Leonidas D. D., Chrysina E. D., Skamnaki V. T., Bischoff H., Goldmann S., Watson K. A., Johnson L. N. The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor. Structure. 1997 Nov 15;5(11):1413–1425. doi: 10.1016/s0969-2126(97)00292-x. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES